Busulfan in Treating Children and Adolescents With Refractory CNS Cancer
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die.
PURPOSE: Phase I trial to study the safety of delivering intrathecal busulfan in children and
adolescents who have refractory CNS cancer and to estimate the maximum tolerated dose of this
treatment regimen.